Caricamento...
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...
Salvato in:
| Pubblicato in: | Breast Cancer (Dove Med Press) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063595/ https://ncbi.nlm.nih.gov/pubmed/27785100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S114659 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|